CIT completed Lab Research takeover
French contract research organisation (CRO) CIT has completed its acquisition of Canadian counterpart Lab Research.
French contract research organisation (CRO) CIT has completed its acquisition of Canadian counterpart Lab Research.
Biocon contract research revenues jumped 20 per cent in the fourth quarter as a relationship with B-MS ramped up.
US drug developer, PharmStar Pharmaceuticals, has reached an agreement to buy a new 24,000 square foot manufacturing facility in Wilson, North Carolina.
update
Royal DSM NV says its pharmaceutical contract manufacturing business model is ‘out of step with market needs’ after the unit’s Q1 performance blots an otherwise positive set of financials.
PPD pointed to three first quarter strategic deals, in Phase I and cGMP, as evidence its laboratory business will improve later in 2011.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at DSM, Mersana and Diamyd Medical.
Switzerland – based specialty chemicals group Clariant has acquired 96.15 per cent of German Süd – Chemie.